208 related articles for article (PubMed ID: 20554932)
1. Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates.
Bello NT; Kemm MH; Ofeldt EM; Moran TH
Am J Physiol Regul Integr Comp Physiol; 2010 Sep; 299(3):R945-52. PubMed ID: 20554932
[TBL] [Abstract][Full Text] [Related]
2. The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size.
Scott KA; Moran TH
Am J Physiol Regul Integr Comp Physiol; 2007 Sep; 293(3):R983-7. PubMed ID: 17581835
[TBL] [Abstract][Full Text] [Related]
3. Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys.
Bello NT; Kemm MH; Moran TH
Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R76-81. PubMed ID: 18480241
[TBL] [Abstract][Full Text] [Related]
4. Effects of amylin and salmon calcitonin on feeding and drinking behavior in pygmy goats.
Del Prete E; Schade B; Riediger T; Lutz TA; Scharrer E
Physiol Behav; 2002 Apr; 75(4):593-9. PubMed ID: 12062324
[TBL] [Abstract][Full Text] [Related]
5. Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations.
Liang NC; Bello NT; Moran TH
Int J Obes (Lond); 2013 Feb; 37(2):272-8. PubMed ID: 22310470
[TBL] [Abstract][Full Text] [Related]
6. Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats.
Reidelberger RD; Kelsey L; Heimann D
Am J Physiol Regul Integr Comp Physiol; 2002 May; 282(5):R1395-404. PubMed ID: 11959682
[TBL] [Abstract][Full Text] [Related]
7. Behavioural profile of exendin-4/naltrexone dose combinations in male rats during tests of palatable food consumption.
Wright FL; Rodgers RJ
Psychopharmacology (Berl); 2014 Sep; 231(18):3729-44. PubMed ID: 24682505
[TBL] [Abstract][Full Text] [Related]
8. Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner.
Zhao S; Kanoski SE; Yan J; Grill HJ; Hayes MR
Int J Obes (Lond); 2012 Dec; 36(12):1522-8. PubMed ID: 22249232
[TBL] [Abstract][Full Text] [Related]
9. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats.
Mollet A; Gilg S; Riediger T; Lutz TA
Physiol Behav; 2004 Mar; 81(1):149-55. PubMed ID: 15059694
[TBL] [Abstract][Full Text] [Related]
10. Amylin receptors mediate the anorectic action of salmon calcitonin (sCT).
Lutz TA; Tschudy S; Rushing PA; Scharrer E
Peptides; 2000 Feb; 21(2):233-8. PubMed ID: 10764950
[TBL] [Abstract][Full Text] [Related]
11. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
Bojanowska E; Radziszewska E
J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
[TBL] [Abstract][Full Text] [Related]
12. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
13. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
[TBL] [Abstract][Full Text] [Related]
14. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
Radziszewska E; Bojanowska E
Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
[TBL] [Abstract][Full Text] [Related]
16. Concurrent pharmacological modification of cannabinoid-1 and glucagon-like peptide-1 receptor activity affects feeding behavior and body weight in rats fed a free-choice, high-carbohydrate diet.
Radziszewska E; Wolak M; Bojanowska E
Behav Pharmacol; 2014 Feb; 25(1):53-60. PubMed ID: 24370558
[TBL] [Abstract][Full Text] [Related]
17. Interactions between leptin and exendin-4, a glucagon-like peptide-1 agonist, in the regulation of food intake in the rat.
Bojanowska E; Nowak A
J Physiol Pharmacol; 2007 Jun; 58(2):349-60. PubMed ID: 17622702
[TBL] [Abstract][Full Text] [Related]
18. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
19. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).
Young AA; Gedulin BR; Bhavsar S; Bodkin N; Jodka C; Hansen B; Denaro M
Diabetes; 1999 May; 48(5):1026-34. PubMed ID: 10331407
[TBL] [Abstract][Full Text] [Related]
20. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
